Wei Zhang
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Assistant Professor - Tenure Track
Faculty Researcher
Upstream record may be merged OpenAlex, the source of these figures, lists 226 institutions in 12 countries for this author record — a pattern that usually means it combines several researchers with similar names. The totals above may include work by other people.
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Wei Zhang's research investigates the molecular mechanisms underlying disease, with a focus on cancer, cardiovascular disease, and neurological disorders. His work has explored the role of specific genes and signaling pathways in disease progression, including the impact of LDHA on epithelial-mesenchymal transition and metastasis in papillary thyroid carcinoma, and the influence of the GABAergic system in central nervous system diseases. Zhang has also contributed to research on atherosclerosis, examining the anti-inflammatory effects of biomimetic Prussian blue analogues and glycosides from Buyang Huanwu Decoction via the JAK/STAT signaling pathway.
Further research interests include the application of advanced technologies for disease detection and gene editing. This includes the development of electrochemical biosensors for pathogen detection using CRISPR/Cas12a technology and the use of prime editing in mice to study tissue-specific gene expression. Zhang's scholarly output is substantial, reflected in a high citation count of 6,678 and an h-index of 46 across nearly 300 publications. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Jeanne Y. Wei and Gohar Azhar, on multiple occasions.
Metrics
- h-index: 46
- Publications: 297
- Citations: 6,678
Selected Publications
-
Survival benefit associated with liver transplantation for hepatocellular carcinoma based on tumor burden scores at listing (2025)
-
Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer (2024)
Collaboration Network
Top Collaborators
- Differential plasma protein expression after ingestion of essential amino acid-based dietary supplement verses whey protein in low physical functioning older adults
- Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer
- Differential plasma protein expression after ingestion of essential amino acid-based dietary supplement verses whey protein in low physical functioning older adults
- Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer
- Differential plasma protein expression after ingestion of essential amino acid-based dietary supplement verses whey protein in low physical functioning older adults
- Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer
- Differential plasma protein expression after ingestion of essential amino acid-based dietary supplement verses whey protein in low physical functioning older adults
- Differential plasma protein expression after ingestion of essential amino acid-based dietary supplement verses whey protein in low physical functioning older adults
- Differential plasma protein expression after ingestion of essential amino acid-based dietary supplement verses whey protein in low physical functioning older adults
- Differential plasma protein expression after ingestion of essential amino acid-based dietary supplement verses whey protein in low physical functioning older adults
- Differential plasma protein expression after ingestion of essential amino acid-based dietary supplement verses whey protein in low physical functioning older adults
- Differential plasma protein expression after ingestion of essential amino acid-based dietary supplement verses whey protein in low physical functioning older adults
- Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer
- Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer
- Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer
- Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer
- Survival benefit associated with liver transplantation for hepatocellular carcinoma based on tumor burden scores at listing
- Survival benefit associated with liver transplantation for hepatocellular carcinoma based on tumor burden scores at listing
Similar Researchers
Based on overlapping research topics